Earnings Gauntlet: Bears, Analysts, and Insiders All Move at Once

The biggest earnings week of 2026 is here. Markets are bracing for results from biotech, travel, and consumer names simultaneously. Short sellers, options traders, and insiders are all taking sides before the data drops.

Earnings Front and Centre

AMGN headlines Tuesday after the close alongside GILD and BKNG. Booking Holdings' $150bn market cap makes it the clearest read on global travel demand. MAR reports Monday morning. PGR follows Tuesday. MCD is also on the calendar this week, alongside a closely watched monthly US jobs report. The macro and micro are colliding.

Bears Already Positioned

Short sellers aren't waiting. HTZ short interest sits at 84.6% of free float. CHWY hit 82.4%, up 10 points in a week. Both report this week. Options flow reinforces the bearish tone. MU leads negative bets in semiconductors. TSLA also draws heavy put activity with its RSI near 30 — close to oversold.

Analysts Back Pharma

Wall Street lifted targets on REGN and BIIB today. Both benefit from strong drug pipelines. Construction materials told a different story. MLM saw its target trimmed to $671.61. Analysts are cooling on infrastructure plays.

Europe and FX in Focus

The yen jumped 3% amid speculation of intervention by Tokyo authorities. The New York Fed sold euros to buy yen in a rare move. South Korean equities surged 18% as AI-linked chipmakers rebounded sharply after a bruising month. London's FCA outlined plans to revive domestic share trading with a single data stream reform.

Notable Insider Activity

SCHW founder Charles Schwab filed sales totalling nearly $20M between July 24 and July 29. Citizens Financial CEO Bruce Van Saun sold $9.3M in CFG shares. Both names have run hard in 2026.